Abstract
Radioactive iodine therapy (RAI) has been used in patients with differentiated thyroid cancers (DTC) for many decades. However, many changes in thyroid cancer treatment have been introduced for the last decade worldwide, mainly a tendency to deescalate both surgical and adjuvant treatment has been observed. This work summarizes current Polish guidelines for adjuvant radioiodine therapy compared to American Thyroid Association recommendations.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
